Llore Nathaly P, Bruestle Karina A, Griesemer Adam
Columbia Center for Translational Immunology, Columbia University College of Physicians and Surgeons.
Department of Surgery, Columbia University, New York, New York, USA.
Curr Opin Organ Transplant. 2018 Dec;23(6):642-648. doi: 10.1097/MOT.0000000000000585.
The aim of this study was to review the recent progress in xenotransplantation achieved through genetic engineering and discuss the potential of tolerance induction to overcome remaining barriers to extended xenograft survival.
The success of life-saving allotransplantation has created a demand for organ transplantation that cannot be met by the supply of human organs. Xenotransplantation is one possible solution that would allow for a nearly unlimited supply of organs. Recent genetic engineering of swine has decreased the reactivity of preformed antibodies to some, but not all, potential human recipients. Experiments using genetically modified swine organs have now resulted in survival of life-supporting kidneys for over a year. However, the grafts show evidence of antibody-mediated rejection on histology, suggesting additional measures will be required for further extension of graft survival. Tolerance induction through mixed chimerism or thymic transplantation across xenogeneic barriers would be well suited for patients with a positive crossmatch to genetically modified swine or relatively negative crossmatches to genetically modified swine, respectively.
This review highlights the current understanding of the immunologic processes in xenotransplantation and describes the development and application of strategies designed to overcome them from the genetic modification of the source animal to the induction of tolerance to xenografts.
本研究旨在回顾通过基因工程在异种移植方面取得的最新进展,并探讨诱导耐受以克服延长异种移植物存活的剩余障碍的潜力。
挽救生命的同种异体移植的成功导致了对器官移植的需求,而人体器官供应无法满足这一需求。异种移植是一种可能的解决方案,可提供几乎无限的器官供应。最近对猪的基因工程改造降低了预先形成的抗体对部分但并非所有潜在人类受者的反应性。使用转基因猪器官的实验现已使维持生命的肾脏存活超过一年。然而,组织学检查显示移植物有抗体介导排斥的迹象,这表明需要采取额外措施来进一步延长移植物存活时间。通过混合嵌合体或跨异种屏障的胸腺移植诱导耐受,分别适用于与转基因猪交叉配型阳性或交叉配型相对阴性的患者。
本综述强调了目前对异种移植免疫过程的理解,并描述了从源动物的基因改造到诱导对异种移植物的耐受等旨在克服这些过程的策略的发展和应用。